Stuart Rich
2023
In 2023, Stuart Rich earned a total compensation of $481.2K as Chief Medical Officer at Tenax Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $127,200 |
---|---|
Salary | $318,000 |
Other | $36,023 |
Total | $481,223 |
Rich received $318K in salary, accounting for 66% of the total pay in 2023.
Rich also received $127.2K in non-equity incentive plan and $36K in other compensation.
Rankings
In 2023, Stuart Rich's compensation ranked 2,083rd out of 3,006 executives tracked by ExecPay. In other words, Rich earned more than 30.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,083 out of 3,006 | 31st |
Division Manufacturing | 1,190 out of 1,650 | 28th |
Major group Chemicals And Allied Products | 729 out of 918 | 21st |
Industry group Drugs | 712 out of 881 | 19th |
Industry Pharmaceutical Preparations | 513 out of 637 | 20th |
Source: SEC filing on September 27, 2024.
Rich's colleagues
We found two more compensation records of executives who worked with Stuart Rich at Tenax Therapeutics in 2023.